Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Hall

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Pain Medicine (Malden, Mass.)|November 3, 2010
Dexmedetomidine infusion for the management of opioid-induced hyperalgesiaMiles Belgrade, Sara Hall
Blood|February 21, 2020
Mott cells: pearls of pathologyZi Yun Ng, Sara Hall
Pathology|August 28, 2014
A survey of Australian haematology reference intervalsLeanne Sinclair, Sara Hall, Tony Badrick
Plos One|August 21, 2025
Olfactory dysfunction and amyloid-positivity in Parkinson's disease-longitudinal analysis of cognitive decline and cerebrospinal fluid markersVictoria Larsson, Sara Hall, Kaj Blennow, et al.
Plos One|April 30, 2013
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophyEli Kaufman, Sara Hall, Yulia Surova, et al.
Alzheimer'S Research & Therapy|October 6, 2015
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patientsMalin Wennström, Sara Hall, Katarina Nägga, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 17, 2016
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's DiseaseSara Hall, Yulia Surova, Annika Öhrfelt, et al.
Plos One|October 20, 2012
Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serumDaniel Lindqvist, Eli Kaufman, Lena Brundin, et al.
Scientific Reports|September 7, 2018
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disordersSara Hall, Shorena Janelidze, Yulia Surova, et al.
Neurology|November 21, 2014
CSF biomarkers and clinical progression of Parkinson diseaseSara Hall, Yulia Surova, Annika Öhrfelt, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Pain Medicine (Malden, Mass.)|November 3, 2010
Dexmedetomidine infusion for the management of opioid-induced hyperalgesiaMiles Belgrade, Sara Hall
Blood|February 21, 2020
Mott cells: pearls of pathologyZi Yun Ng, Sara Hall
Pathology|August 28, 2014
A survey of Australian haematology reference intervalsLeanne Sinclair, Sara Hall, Tony Badrick
Plos One|August 21, 2025
Olfactory dysfunction and amyloid-positivity in Parkinson's disease-longitudinal analysis of cognitive decline and cerebrospinal fluid markersVictoria Larsson, Sara Hall, Kaj Blennow, et al.
Plos One|April 30, 2013
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophyEli Kaufman, Sara Hall, Yulia Surova, et al.
Alzheimer'S Research & Therapy|October 6, 2015
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patientsMalin Wennström, Sara Hall, Katarina Nägga, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 17, 2016
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's DiseaseSara Hall, Yulia Surova, Annika Öhrfelt, et al.
Plos One|October 20, 2012
Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serumDaniel Lindqvist, Eli Kaufman, Lena Brundin, et al.
Scientific Reports|September 7, 2018
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disordersSara Hall, Shorena Janelidze, Yulia Surova, et al.
Neurology|November 21, 2014
CSF biomarkers and clinical progression of Parkinson diseaseSara Hall, Yulia Surova, Annika Öhrfelt, et al.
Pageof 6